Chen Min, Chen Zhi, Ye Huarong, Cheng Yuanling, Jin Zhigang, Cai Shaoqian
Department of Cardiology, China Resources & Wisco General Hospital, Wuhan University of Science and Technology, Wuhan, China.
Medical College of Wuhan University of Science and Technology, Wuhan, China.
Front Cardiovasc Med. 2024 Jul 8;11:1286091. doi: 10.3389/fcvm.2024.1286091. eCollection 2024.
Despite reducing low-density lipoprotein cholesterol (LDL-C) to the normal range, residual cardiovascular risk remain. Remnant cholesterol (RC) exerts a potential residual risk for cardiovascular disease (CVD) prevention, and the long-term longitudinal association between RC and mortality has yet to be well elucidated.
This study examined a nationally representative sample of 13,383 adults aged 20 years or older (mean age 45.7 and 52% women) who participated in the NHANES III (from1988 to1994). Causes of death were ascertained by linkage to death records through December 31, 2019. The relations of RC with all-cause and CVD mortality were tested using weighted Cox proportional hazard models.
Through a median follow-up of 26.6 years, 5,044 deaths were reported, comprising 1,741 deaths of CVD [1,409 deaths of ischemic heart disease (IHD) and 332 deaths of stroke] and 1,126 of cancer. Compared to those with RC <14.26 mg/dl (lowest quartile), participants with RC ≥29.80 mg/dl (highest quartile) had multivariable-adjusted HRs of 1.23 (95% CI: 1.07-1.42) for all-cause mortality, 1.22 (95% CI: 0.97-1.53) for CVD mortality, and 1.32 (95% CI: 1.03-1.69) for IHD mortality, and 0.89 (95% CI: 0.55-1.43) for stroke mortality, and 1.17 (95% CI 0.90-1.52) for cancer mortality. We observed that elevated RC levels increased CVD risk and IHD mortality despite LDL-C being in the normal range.
Elevated blood RC was associated with an increased long-term risk of all-cause, CVD, and IHD mortality. These associations were independent of socioeconomic factors, lifestyles, and history of diseases, and remained robust across the LDL-C stratum. Measuring RC levels might favor clinical assessment of early CVD risk. Further investigation is needed to elucidate the optimal range of RC levels for cardiovascular disease health in the general population.
尽管已将低密度脂蛋白胆固醇(LDL-C)降至正常范围,但心血管残余风险依然存在。残留胆固醇(RC)对心血管疾病(CVD)预防存在潜在的残余风险,而RC与死亡率之间的长期纵向关联尚未得到充分阐明。
本研究对参加第三次美国国家健康与营养检查调查(NHANES III,1988年至1994年)的13383名20岁及以上成年人(平均年龄45.7岁,女性占52%)进行了具有全国代表性的抽样调查。通过与截至2019年12月31日的死亡记录相链接来确定死亡原因。使用加权Cox比例风险模型检验RC与全因死亡率和CVD死亡率之间的关系。
经过中位数为26.6年的随访,共报告了5044例死亡,其中包括1741例CVD死亡[1409例缺血性心脏病(IHD)死亡和332例中风死亡]以及1126例癌症死亡。与RC<14.26mg/dl(最低四分位数)的参与者相比,RC≥29.80mg/dl(最高四分位数)的参与者全因死亡率的多变量调整风险比(HR)为1.23(95%置信区间:1.07-1.42),CVD死亡率为1.22(95%置信区间:0.97-1.53),IHD死亡率为1.32(95%置信区间:1.03-1.69),中风死亡率为0.89(95%置信区间:0.55-1.43),癌症死亡率为1.17(95%置信区间0.90-1.52)。我们观察到,尽管LDL-C处于正常范围,但RC水平升高会增加CVD风险和IHD死亡率。
血液RC升高与全因、CVD和IHD死亡率的长期风险增加相关。这些关联独立于社会经济因素、生活方式和疾病史,并且在LDL-C分层中仍然显著。测量RC水平可能有助于早期CVD风险的临床评估。需要进一步研究以阐明一般人群中心血管疾病健康的RC水平最佳范围。